- Home
- ZCMD vs LGVN Comparison
ZCMD vs LGVN Comparison
Compare ZCMD & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- LGVN
- Stock Information
- Founded
- ZCMD 2012
- LGVN 2014
- Country
- ZCMD China
- LGVN United States
- Employees
- ZCMD N/A
- LGVN N/A
- Industry
- ZCMD Other Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- ZCMD Real Estate
- LGVN Health Care
- Exchange
- ZCMD Nasdaq
- LGVN Nasdaq
- Market Cap
- ZCMD 18.3M
- LGVN 16.4M
- IPO Year
- ZCMD 2020
- LGVN 2021
- Fundamental
- Price
- ZCMD $0.68
- LGVN $0.92
- Analyst Decision
- ZCMD
- LGVN Strong Buy
- Analyst Count
- ZCMD 0
- LGVN 2
- Target Price
- ZCMD N/A
- LGVN $6.50
- AVG Volume (30 Days)
- ZCMD 801.6K
- LGVN 558.5K
- Earning Date
- ZCMD 01-01-0001
- LGVN 11-11-2025
- Dividend Yield
- ZCMD N/A
- LGVN N/A
- EPS Growth
- ZCMD N/A
- LGVN N/A
- EPS
- ZCMD N/A
- LGVN N/A
- Revenue
- ZCMD $13,117,523.00
- LGVN $2,073,000.00
- Revenue This Year
- ZCMD N/A
- LGVN N/A
- Revenue Next Year
- ZCMD N/A
- LGVN N/A
- P/E Ratio
- ZCMD N/A
- LGVN N/A
- Revenue Growth
- ZCMD N/A
- LGVN 68.67
- 52 Week Low
- ZCMD $0.64
- LGVN $0.63
- 52 Week High
- ZCMD $2.50
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- ZCMD 31.22
- LGVN 60.97
- Support Level
- ZCMD $0.64
- LGVN $0.75
- Resistance Level
- ZCMD $0.83
- LGVN $0.85
- Average True Range (ATR)
- ZCMD 0.07
- LGVN 0.06
- MACD
- ZCMD -0.01
- LGVN 0.02
- Stochastic Oscillator
- ZCMD 16.35
- LGVN 70.91
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.